Poustchi, Hossein

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics

Inflammatory Bowel DiseaseGenetic Associations and Epidemiology

Cited by 2,603

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., et al. (2020) · The Lancet Gastroenterology & Hepatology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 2,313

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

Zhou, B., Rayner, A. W., Gregg, E. W., Sheffer, K. E., Carrillo-Larco, R. M., Bennett, J. E., Shaw, J. E., Paciorek, C. J., Singleton, R. K., Barradas Pires, A., et al. (2024) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 1,013

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial

Saadati, S., Sadeghi, A., Mansour, A., Yari, Z., Poustchi, H., Hedayati, M., Hatami, B., & Hekmatdoost, A. (2019) · BMC Gastroenterology

Curcumin's Biomedical ApplicationsLiver Disease Diagnosis and Treatment

Cited by 164

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study

Yari, Z., Rahimlou, M., Eslamparast, T., Ebrahimi-Daryani, N., Poustchi, H., & Hekmatdoost, A. (2016) · International Journal of Food Sciences and Nutrition

Liver Disease Diagnosis and TreatmentSilymarin and Mushroom Poisoning

Cited by 118

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease

Saadati, S., Hatami, B., Yari, Z., Shahrbaf, M. A., Eghtesad, S., Mansour, A., Poustchi, H., Hedayati, M., Aghajanpoor-pasha, M., Sadeghi, A., et al. (2019) · European Journal of Clinical Nutrition

Curcumin's Biomedical ApplicationsLiver Disease Diagnosis and Treatment

Cited by 110

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial

Mansour, A., Mohajeri-Tehrani, M. R., Samadi, M., Qorbani, M., Merat, S., Adibi, H., Poustchi, H., & Hekmatdoost, A. (2021) · Nutrition Journal

Coffee research and impactsLiver Disease Diagnosis and Treatment

Cited by 98

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

Hashemi Madani, N., Ismail-Beigi, F., Poustchi, H., Nalini, M., Sepanlou, S. G., Malek, M., Abbasi, M. A., Khajavi, A., Khamseh, M. E., & Malekzadeh, R. (2020) · BMC Cardiovascular Disorders

Diabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension Studies

Cited by 22

The effect of intermittent fasting diet in comparison with low-calorie diet on inflammation, lipid profile, glycemic index, liver fibrosis in patients with metabolic-associated fatty liver disease (MAFLD): a randomized controlled trial

Karimi, M., Akhgarjand, C., Houjaghani, H., Nejad, M. M., Sohrabpour, A. A., Poustchi, H., Mohammadi, H., Chamari, M., & Imani, H. (2025) · Clinical Therapeutics

Liver Disease Diagnosis and TreatmentDietary Effects on Health

Cited by 12